Guidelines for atrial fibrillation in heart failure need to be clarified.
Smit
Marcelle D
MD
Van Veldhuisen
Dirk J
DJ
Van Gelder
Isabelle C
IC
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000628:therapy*; D006333:Heart Failure / Q000150:complications* / Q000628:therapy*; D006801:Humans; D017410:Practice Guidelines as Topic
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants